• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Cyclacel Pharmaceuticals, Inc. (CYCC)

    -NasdaqGM
    0.68 Down 0.04(5.07%) Dec 19, 4:00PM EST
    |After Hours : 0.68 0.00 (0.00%) Dec 19, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 1,084   69   -  
    Cost of Revenue -   -   -  
    Gross Profit 1,084   69   -  
    Operating Expenses
    Research Development11,277  6,592  9,206  
    Selling General and Administrative7,781  8,580  6,542  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (17,974) (15,103) (15,748)
    Income from Continuing Operations
    Total Other Income/Expenses Net6,094  (4)580  
    Earnings Before Interest And Taxes(11,880)(15,107)(15,168)
    Interest Expense -   -   -  
    Income Before Tax(11,880)(15,107)(15,168)
    Income Tax Expense(1,670)(1,351)(565)
    Minority Interest -   -   -  
    Net Income From Continuing Ops(10,210)(13,756)(14,603)
    Non-recurring Events
    Discontinued Operations57  570  (640)
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (10,153) (13,186) (15,243)
    Preferred Stock And Other Adjustments(9,325)(728)(728)
    Net Income Applicable To Common Shares (19,478) (13,914) (15,971)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.